Stay updated on Pembrolizumab Combo in ES-SCLC Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab Combo in ES-SCLC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab Combo in ES-SCLC Clinical Trial page

  1. Check
    5 days ago
    No Change Detected
  2. Check
    12 days ago
    No Change Detected
  3. Check
    19 days ago
    Change Detected
    Summary
    The page’s displayed revision/version number has been updated from v3.5.2 to v3.5.3.
    Difference
    0.0%
    Check dated 2026-04-25T18:52:22.000Z thumbnail image
  4. Check
    27 days ago
    Change Detected
    Summary
    The location entry for Vienna was updated from 'Vienna, Vienna, Austria, 1140' to 'Vienna, State of Vienna, Austria, 1140', and the page revision changed from v3.5.0 to v3.5.2.
    Difference
    0.1%
    Check dated 2026-04-18T13:51:50.000Z thumbnail image
  5. Check
    48 days ago
    Change Detected
    Summary
    Added the disease term Small cell lung carcinoma and the Genetic and Rare Diseases Information Center as a resources entry.
    Difference
    0.1%
    Check dated 2026-03-28T03:24:29.000Z thumbnail image
  6. Check
    55 days ago
    Change Detected
    Summary
    Study protocol revision updated from v3.4.3 to v3.5.0.
    Difference
    0.0%
    Check dated 2026-03-21T01:03:59.000Z thumbnail image
  7. Check
    69 days ago
    Change Detected
    Summary
    - Revision: v3.4.3 has been added and Revision: v3.4.2 has been removed.
    Difference
    0.0%
    Check dated 2026-03-06T19:02:52.000Z thumbnail image
  8. Check
    91 days ago
    Change Detected
    Summary
    Revision updated from v3.4.1 to v3.4.2 on the page; this is a minor version change with no impact on core content — To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2026-02-13T11:46:13.000Z thumbnail image

Stay in the know with updates to Pembrolizumab Combo in ES-SCLC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab Combo in ES-SCLC Clinical Trial page.